CLASS II Device recall · Reported 24 Dec 2014 · FDA Enforcement Report

Turbo Troponin I For in vitro diagnostic use recalled

Siemens Healthcare Diagnostics is recalling Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin, distributed in Colorado, Florida, Minnesota, Montana, New York. The recall was initiated on 27 Oct 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog #'s: 1) LSKTI1 and 2) LSKTI1(D); Siemens Material Number (SMN): 1) 10642238 (US) and 2) 10381014 (OUS); Lot Numbers: 319, 321, 322, 323 and D319, D321 and D322.
Quantity recalled3,622 kits (3,572 domestic and 50 internationally)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0801-2015
FDA event ID
69718
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Terminated
Recall initiated
27 Oct 2014
FDA classified
12 Dec 2014
Reported
24 Dec 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

27 Oct 2014Recall initiated by company
12 Dec 2014Classified by FDA+46 days
24 Dec 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Not stated in the enforcement report.

Product as listed by the FDA

Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin I in serum, heparinized or EDTA plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).

Where it was distributed

Worldwide Distribution: US distribution in states of: CO, FL, MN, MT, and NY; and countries of: Algeria, Argentina, Bolivia, Brazil, Bulgaria, Chile, Columbia, Czech Republic, Ecuador, Egypt, Germany, Hungary, India, Italy, Lithuania, Latvia, Pakistan, Poland, Romania, Russian Fed., Serbia, South Africa, Slovakia, Thailand, Tunisia, and Uruguay.

ColoradoFloridaMinnesotaMontanaNew York

Questions about this recall

Is Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin recalled?

Yes. Siemens Healthcare Diagnostics recalled Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin on 27 Oct 2014. The recall is Class II and its status is Terminated. Recall number Z-0801-2015.

Why was it recalled?

The reason has not been published.

Which lots are affected?

Catalog #'s: 1) LSKTI1 and 2) LSKTI1(D); Siemens Material Number (SMN): 1) 10642238 (US) and 2) 10381014 (OUS); Lot Numbers: 319, 321, 322, 323 and D319, D321 and D322.

Where was it sold?

Worldwide Distribution: US distribution in states of: CO, FL, MN, MT, and NY; and countries of: Algeria, Argentina, Bolivia, Brazil, Bulgaria, Chile, Columbia, Czech Republic, Ecuador, Egypt, Germany, Hungary, India, Italy, Lithuania, Latvia, Pakistan, Poland, Romania, Russian Fed., Serbia, South Africa, Slovakia, Thailand, Tunisia, and Uruguay.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656